India, Oct. 15 -- Novo India has introduced a significant price reduction of upto 35% for Norditropin(R) FlexPro(R) for adults & children living with growth hormone deficiency in India. Effective today, this innovative growth hormone therapy will be available with a new India-specific pricing in two dose strengths - 10 mg & 15 mg.

The price of the 10mg device has been reduced by 33%, from Rs 16,836 to Rs 11,300, while for 15mg device price has been reduced by 35%, from Rs 25,254 to Rs 16,450 - translating to savings of Rs 5,539 and Rs 8,802 per pen, respectively.

This significant step is part of Novo's continued commitment to expanding access and affordability to essential therapies for people living with growth hormone deficiency and r...